Strength
100 mg/.67mL
Manufacturer
Swedish Orphan Biovitrum AB (publ)NDC
66658023428
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
1/1/2016
Active Ingredients
ANAKINRAApproval Type
Biologic (BLA)
FDA Application
BLA103950On Market Since
12/15/2009
Pharmacological Classes
Interleukin 1 Receptor Antagonists
Interleukin-1 Receptor Antagonist
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
No related drugs found.